E75.240 Niemann-Pick disease type A

✓ Billable ICD-10-CM 2026
Open E75.240 in Web App →

The ICD-10-CM code for Niemann-Pick disease type A is E75.240 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
E70-E88: Metabolic disorders (E70-E88)
Category E75
31 codes (26 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to E75.240:

  • Deficiency, deficient › infantile neurovisceral acid sphingomyelinase
  • Niemann-Pick disease or syndrome › type › A
  • Deficiency, deficient › acid sphingomyelinase (ASMD) › type › A

Inclusion Terms

  • Acid sphingomyelinase deficiency type A (ASMD type A)
  • Infantile neurovisceral acid sphingomyelinase deficiency

U.S. Hospital Utilization

E75.240 appeared in too few sampled U.S. inpatient stays in 2023 to report a national estimate (AHRQ suppresses counts of 10 or fewer) — a rare inpatient diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Diabetes mellitus (TOC entry)

a. Diabetes mellitus ................................................................................................................... 39

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.4.a
Obesity (TOC entry)

b. Obesity .................................................................................................................................. 42

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.4.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial